Shanghai Pioneer Holding Ltd (HKG:1345)

Market Cap	2.61B -2.6%
Revenue (ttm)	1.49B -17.4%
Net Income	113.95M -33.7%
EPS	0.10 -29.7%
Shares Out	1.16B
PE Ratio	22.92
Forward PE	n/a
Dividend	0.13 (5.93%)
Ex-Dividend Date	Sep 11, 2025

Volume	68,000
Average Volume	51,359
Open	2.240
Previous Close	2.250
Day's Range	2.240 - 2.250
52-Week Range	1.590 - 2.400
Beta	-0.19
RSI	42.62
Earnings Date	Mar 26, 2026

About Shanghai Pioneer Holding

Shanghai Pioneer Holding Ltd, an investment holding company, engages in marketing, promotion, and channel management of pharmaceutical products and medical devices primarily in the People’s Republic of China. It offers pharmaceutical products for ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas; and medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company also engages in the sale of ancillary tools, dental devices, and imported in...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1996
• Employees: 343
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1345

Financial Performance

In 2024, Shanghai Pioneer Holding's revenue was 1.53 billion, a decrease of -2.27% compared to the previous year's 1.57 billion. Earnings were 151.62 million, an increase of 9.46%.

Financial numbers in CNY